Drug Traceability in Supply Chain of Healthcare using Blockchain-Based Approach

  • - P
  • - P
  • - D
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

The supplychain for healthcare is an intricate web of inter connected businesses that includes manufacturers, distributors, pharmacies, hospitals, patients, and suppliersofrawmaterials.Duetoanumberofissues,suchascentralisedcontrol,conflictingstakeholder conduct, and a lack of information, tracking supply across this network is difficult. In additiontocreatinginefficiencieslikethosebroughttolightbytheCOVID-19pandemic[1], this complexity can make it more difficult to mitigate the problem of counterfeit pharmaceuticalsbecausetheycanquicklyinfiltratethehealthcaresupplychain.Drugsthat are intentionally manufactured fraudulently and/or mislabeled with regard to identity and/or source in order to pass for authentic goods are known as counterfeit drugs[2][3]. These prescriptions may include those with no active pharmaceutical ingredient (API), the wrong dosage, the wrong kind of API, a pollutants, or repackaged goods that have expired. It is possible forcertainfake drugs to be manufactured under unsatisfactory circumstances and with improper formulations[4].

Cite

CITATION STYLE

APA

-, Prof. S. S., -, Prof. R. K., & -, Dr. V. W. (2024). Drug Traceability in Supply Chain of Healthcare using Blockchain-Based Approach. International Journal For Multidisciplinary Research, 6(2). https://doi.org/10.36948/ijfmr.2024.v06i02.17739

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free